| Publication |
Sentence |
Publish Date |
Extraction Date |
Species |
| Manabu Takano, Tsuyoshi Okada, Katsutoshi Shioda, Chikara Yonekawa, Shiro Sud. Risperidone suppresses caffeine-induced hyperthermia and hyperactivity in rats. Neuroscience letters. 2024-09-02. PMID:39222834. |
in vivo microdialysis was used to determine the effect of risperidone on caffeine-induced elevation of dopamine (da), serotonin (5-ht), and noradrenaline (na) concentrations in the anterior hypothalamus. |
2024-09-02 |
2024-09-05 |
rat |
| Manabu Takano, Tsuyoshi Okada, Katsutoshi Shioda, Chikara Yonekawa, Shiro Sud. Risperidone suppresses caffeine-induced hyperthermia and hyperactivity in rats. Neuroscience letters. 2024-09-02. PMID:39222834. |
in the microdialysis study, risperidone treatment further attenuated caffeine-induced 5-ht elevation, but not da and na. |
2024-09-02 |
2024-09-05 |
rat |
| Hajar Khazraei, Seyedeh Azra Shamsdi. The anti-inflammatory effects of antidepressants on colitis. Gastroenterology and hepatology from bed to bench. vol 17. issue 1. 2024-05-13. PMID:38737937. |
clomipramine (tricyclic antidepressant), risperidone (a non-typical antidepressant), and escitalopram (selective serotonin reuptake inhibitor antidepressant) might be good candidates for investigating the anti-colitis activity. |
2024-05-13 |
2024-05-27 |
Not clear |
| Julie Martino, Zane Elfessi, Katarzyna Szaflarska, Melody Suh, Katerina Antonishin. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use. Journal of pharmacy practice. 2024-04-19. PMID:38641430. |
serotonin syndrome precipitated by the rapid titration of sertraline and trazodone in the setting of risperidone use. |
2024-04-19 |
2024-04-22 |
Not clear |
| Julie Martino, Zane Elfessi, Katarzyna Szaflarska, Melody Suh, Katerina Antonishin. Take It Easy! Serotonin Syndrome Precipitated by the Rapid Titration of Sertraline and Trazodone in the Setting of Risperidone Use. Journal of pharmacy practice. 2024-04-19. PMID:38641430. |
we report a case that details the presentation and treatment of a 25-year-old man who developed serotonin syndrome in the setting of rapid titration of risperidone, trazodone, and sertraline. |
2024-04-19 |
2024-04-22 |
Not clear |
| Samantha Alvarez-Herrera, Mauricio Rosel Vales, Gilberto Pérez-Sánchez, Enrique Becerril-Villanueva, Yvonne Flores-Medina, José Luis Maldonado-García, Ricardo Saracco-Alvarez, Raúl Escamilla, Lenin Pavó. Risperidone Decreases Expression of Serotonin Receptor-2A (5-HT2A) and Serotonin Transporter (SERT) but Not Dopamine Receptors and Dopamine Transporter (DAT) in PBMCs from Patients with Schizophrenia. Pharmaceuticals (Basel, Switzerland). vol 17. issue 2. 2024-02-24. PMID:38399382. |
risperidone decreases expression of serotonin receptor-2a (5-ht2a) and serotonin transporter (sert) but not dopamine receptors and dopamine transporter (dat) in pbmcs from patients with schizophrenia. |
2024-02-24 |
2024-02-26 |
Not clear |
| Muhammad Ishrat Husain, Daniel M Blumberger, David J Castle, Nicole Ledwos, Elise Fellows, Brett D M Jones, Abigail Ortiz, Stefan Kloiber, Wei Wang, Joshua D Rosenblat, Benoit H Mulsan. Psilocybin for treatment-resistant depression without psychedelic effects: study protocol for a 4-week, double-blind, proof-of-concept randomised controlled trial. BJPsych open. vol 9. issue 4. 2023-07-25. PMID:37489299. |
these effects depend on serotonin 2a (5-ht2a) receptor activation, which can be blocked by 5-ht2a receptor antagonists like ketanserin or risperidone. |
2023-07-25 |
2023-08-14 |
Not clear |
| Saleh I Alaqel, Omeima Abdullah, Adnan Alharbi, Yusuf S Althobaiti, Mansour S Alturki, Sherif Ramzy, Atiah H Almalk. Guava-fruit based synthesis of carbon quantum dots for spectrofluorometric quantitative analysis of risperidone in spiked human plasma and pharmaceutical dosage forms. RSC advances. vol 13. issue 26. 2023-06-16. PMID:37323441. |
risperidone is a selective serotonin type 2 and dopamine type 2 receptor antagonist. |
2023-06-16 |
2023-08-14 |
human |
| Zane Elfessi, Archana Jhawar, Julie Martin. Priapism Associated With the Addition of Hydroxyzine to Risperidone: A Case Report. Journal of pharmacy practice. 2023-05-05. PMID:37144572. |
risperidone is a second-generation antipsychotic that primarily blocks serotonin and dopamine receptors, while also inhibiting alpha-1 and alpha-2 receptors with high affinity. |
2023-05-05 |
2023-08-14 |
Not clear |
| Yoshihiro Iwamura, Tatsuo Nakayama, Atsushi Matsumoto, Yuji Ogi, Masataka Yamaguchi, Atsushi Kobayashi, Kenji Matsumoto, Yasunori Katsura, Naho Konoike, Katsuki Nakamura, Kazuhito Iked. Effect of dopamine receptor-related compounds on naive common marmosets for auditory steady state response. Journal of neurophysiology. 2022-05-18. PMID:35583977. |
subcutaneous administration of the serotonin dopamine antagonist, risperidone (0.3 mg/kg), tended to increase ip and decrease plf, but not significantly. |
2022-05-18 |
2023-08-13 |
Not clear |
| Shuyao Zhang, Wei He, Aiguo Li, Chengkuan Zhao, Yun Chen, Chengcheng Xu, Qiuzhen Zhang, Danling Zheng, Meini Chen, Haixiong Miao, Yihui Huan. Involvement of the TNF-α/SATB2 axis in the induced apoptosis and inhibited autophagy of osteoblasts by the antipsychotic Risperidone. Molecular medicine (Cambridge, Mass.). vol 28. issue 1. 2022-05-03. PMID:35505281. |
risperidone, an atypical antipsychotic, impedes serotonin and dopamine receptor systems. |
2022-05-03 |
2023-08-13 |
Not clear |
| L Rajagopal, C Ryan, A Elzokaky, E S Burstein, H Y Meltze. Pimavanserin augments the efficacy of atypical antipsychotic drugs in a mouse model of treatment-refractory negative symptoms of schizophrenia. Behavioural brain research. 2021-12-15. PMID:34906610. |
by themselves, in sc-pcp mice, the aapds, risperidone, olanzapine, and aripiprazole, but not the selective 5-ht |
2021-12-15 |
2023-08-13 |
mouse |
| Nicole Del Castillo, Bridget Zimmerman M, Billie Tyler, Vicki L Ellingrod, Chadi Calarg. 759C/T Variants of the Serotonin (5-HT2C) Receptor Gene and Weight Gain in Children and Adolescents in Long-Term Risperidone Treatment. Clinical pharmacology & biopharmaceutics. vol 2. issue 2. 2021-10-21. PMID:24772381. |
759c/t variants of the serotonin (5-ht2c) receptor gene and weight gain in children and adolescents in long-term risperidone treatment. |
2021-10-21 |
2023-08-13 |
Not clear |
| Shaul Schreiber, Chaim G Pic. The Opioid Interactions of the Antipsychotic Medications Risperidone and Amisulpride in Mice and Their Potential Use in the Treatment of Other Non-Psychotic Medical Conditions. Cellular and molecular neurobiology. vol 41. issue 5. 2021-05-28. PMID:33184770. |
risperidone is a neuroleptic with a potent dopamine d2 and serotonin 5-ht2 receptor-blocking activity as well as a high affinity for adrenergic and histamine h1 receptors. |
2021-05-28 |
2023-08-13 |
mouse |
| Christoph U Correll, Samuele Cortese, Giovanni Croatto, Francesco Monaco, Damir Krinitski, Gonzalo Arrondo, Edoardo G Ostinelli, Caroline Zangani, Michele Fornaro, Andrés Estradé, Paolo Fusar-Poli, Andre F Carvalho, Marco Solm. Efficacy and acceptability of pharmacological, psychosocial, and brain stimulation interventions in children and adolescents with mental disorders: an umbrella review. World psychiatry : official journal of the World Psychiatric Association (WPA). vol 20. issue 2. 2021-05-27. PMID:34002501. |
based on the meta-analytic evidence, the most convincing efficacy profile emerged for amphetamines, methylphenidate and, to a smaller extent, behavioral therapy in attention-deficit/hyperactivity disorder; aripiprazole, risperidone and several psychosocial interventions in autism; risperidone and behavioral interventions in disruptive behavior disorders; several antipsychotics in schizophrenia spectrum disorders; fluoxetine, the combination of fluoxetine and cognitive behavioral therapy (cbt), and interpersonal therapy in depression; aripiprazole in mania; fluoxetine and group cbt in anxiety disorders; fluoxetine/selective serotonin reuptake inhibitors, cbt, and behavioral therapy with exposure and response prevention in obsessive-compulsive disorder; cbt in post-traumatic stress disorder; imipramine and alarm behavioral intervention in enuresis; behavioral therapy in encopresis; and family therapy in anorexia nervosa. |
2021-05-27 |
2023-08-13 |
Not clear |
| Melanie Turne. The role of drugs in the treatment of autism. Australian prescriber. vol 43. issue 6. 2021-02-04. PMID:33363299. |
cognitive behaviour therapy can be effective, but in some cases selective serotonin reuptake inhibitors may have a rolemost patients have problems sleeping, but drugs are not usually used to treat sleep disorders in childrenantipsychotics, such as risperidone, may be considered for irritability and aggression. |
2021-02-04 |
2023-08-13 |
Not clear |
| Sajid Hameed, Mukesh Kumar, Piyush Puri, Fnu Sapna, Pal Satyajit Singh Athwa. Consequences of a Missed History: A Case of Antidepressant Discontinuation Syndrome. Cureus. vol 12. issue 10. 2020-11-20. PMID:33209514. |
it is reported to occur with the use of different classes of antidepressants - selective serotonin reuptake inhibitor (ssri), monoamineoxidase inhibitor (maoi), tricyclic antidepressants (tcas), and atypical antipsychotics like risperidone, trazodone, clozapine, and venlafaxine. |
2020-11-20 |
2023-08-13 |
Not clear |
| Katarzyna Kamińska, Anna Górska, Karolina Noworyta-Sokołowska, Adam Wojtas, Zofia Rogóż, Krystyna Gołembiowsk. The effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex. Pharmacological reports : PR. vol 70. issue 5. 2020-04-14. PMID:32002949. |
the effect of chronic co-treatment with risperidone and novel antidepressant drugs on the dopamine and serotonin levels in the rats frontal cortex. |
2020-04-14 |
2023-08-13 |
rat |
| Young-Chul Chung, Hong-Bai Eu. Hyperprolactinaemia induced by risperidone. The international journal of neuropsychopharmacology. vol 1. issue 1. 2019-11-20. PMID:11281951. |
risperidone is a potent antagonist of both dopamine (d2) and serotonin (5-ht2) receptors, demonstrating improvement of both positive and negative symptoms and a lower propensity for inducing extrapyramidal symptoms (eps) than typical neuroleptics. |
2019-11-20 |
2023-08-12 |
Not clear |
| Jerrold C. Winter, David J. Fiorella, Scott E. Helsley, Richard A. Rabi. Partial generalization of (-)DOM to fluvoxamine in the rat: implications for SSRI-induced mania and psychosis. The international journal of neuropsychopharmacology. vol 2. issue 3. 2019-11-20. PMID:11281985. |
tests of generalization were then conducted with fluvoxamine either alone or in combination with the 5-ht(1a) antagonist, way-100635, the 5-ht(2) antagonist, pirenperone, and the neuroleptics, fluphenazine, chlorpromazine, thioridazine, loxapine, risperidone, and clozapine. |
2019-11-20 |
2023-08-12 |
rat |